A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — experienced vision issues, including three potentially blinding eye conditions.
It is Saturday once again, and that means a new mock draft simulation. As with the last couple of weekends, we have a new three-round simulation for the Arizona Cardinals. In this simulation using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results